Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Nucleic Acid Extraction for Avian Flu Testing

By HospiMedica staff writers
Posted on 12 Jun 2006
An automated method has been developed to extract nucleic acids from bird samples to be tested for avian flu.

The Freidrich-Loeffler-Institute (FLI) Federal Research Institute for Animal Health (Isle of Riems, Germany) has developed this new method of extracting nucleic acids from bird samples to be tested for avian influenza. More...
The Tecan Freedom Evo 200 liquid handling workstation, a product of Tecan Deutschland GmbH, (Crailsheim, Germany), together with the Macherey-Nagel (Düren, Germany) NucleoSpin viral kit, provide a fast reliable method for maximum recovery of viral RNA.

Dr. Markus Durban, who is responsible for establishing the robotic system at FLI, said, "There is good compatibility between the Tecan workstation and the Macherey-Nagel kit so we quickly established a stable working protocol for RNA extraction and this set-up allows 96 samples to be extracted in parallel in one and a half hours.”

Dr. Bernd Hoffmann, senior scientist at FLI, explained: "We compared several automatic systems for the nucleic acid extraction and, based on these tests, we believe that the Tecan equipment is suitable for sensitive and robust extraction of nucleic acid with minimal cross-contamination.”

Tecan specializes in the development, production, and distribution of advanced automation solutions for pharmaceutical and academic research, diagnostics, food and veterinary research, as well as forensics. Tecan is a supplier of compound and sample storage, management, and logistics solutions. Tecan's clients are pharmaceutical and biotechnology companies, university research departments, and diagnostic laboratories.



Related Links:
Tecan
Macherey-Nagel

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.